Chemo brain: From discerning mechanisms to lifting the brain fog-An aging connection

Cell Cycle. 2017 Jul 18;16(14):1345-1349. doi: 10.1080/15384101.2017.1334022. Epub 2017 Jun 28.

Abstract

Mounting evidence indicates that cancer treatments cause numerous deleterious effects, including central nervous system (CNS) toxicity. Chemotherapy-caused CNS side effects encompass changes in cognitive function, memory, and attention, to name a few. Although chemotherapy treatment-induced side effects occur in 16-75% of all patients, the mechanisms of these effects are not well understood. We have recently proposed a new epigenetic theory of chemo brain and, in a pioneer study, determined that cytotoxic chemotherapy agents induce oxidative DNA damage and affect molecular and epigenetic processes in the brain, and may be associated with brain aging processes. In this paper, we discuss the implications of chemo brain epigenetic effects and future perspectives, as well as outline potential links with brain aging and future translational research opportunities.

Keywords: epigenetics; hippocampus; prefrontal cortex; sex differences in brain.

MeSH terms

  • Aging / drug effects*
  • Aging / genetics
  • Aging / metabolism
  • Animals
  • Antineoplastic Agents / toxicity*
  • Cognitive Dysfunction / chemically induced
  • Cognitive Dysfunction / genetics*
  • Cognitive Dysfunction / metabolism
  • Cognitive Dysfunction / pathology
  • DNA Damage
  • DNA Methylation
  • Epigenesis, Genetic*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Humans
  • Mice
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Oxidative Stress
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / metabolism
  • Prefrontal Cortex / pathology
  • Sex Factors

Substances

  • Antineoplastic Agents